Episode Summary
Executive Summary: Tim Ferriss and Dr. Dominic D’Agostino explore ketosis, exogenous ketones, fasting, and metabolic therapies for Alzheimer’s, cancer, psychiatry, and performance. The conversation emphasizes ketones as both fuel and signaling molecules, discusses practical protocols and supplement choices, and flags risks like chronic use of certain ketone esters. They also cover biomarkers, hyperbaric oxygen, melatonin, and personalized metabolic monitoring.
Main Topics: Ketones as fuel and signaling molecules (Priority: 5/5): The discussion frames ketones as more than an alternative fuel: beta-hydroxybutyrate may influence gene expression, inflammation, and cellular defense pathways, with implications for neurodegeneration and chronic disease. Alzheimer’s disease and metabolic dysfunction (Priority: 5/5): Dom explains how impaired glucose metabolism, neuroinflammation, and possible infectious triggers may contribute to Alzheimer’s, and why ketones can temporarily rescue brain energy deficits and symptoms. Fasting, sardine fasting, and autophagy (Priority: 4/5): The speakers compare water fasting, ketogenic diets, and Dom’s sardine fasting approach as ways to induce caloric restriction, lower inflammation, and support autophagy while preserving nutrition. Supplement strategy, dosing, and safety (Priority: 5/5): They discuss ketone salts, ketone esters, MCT oil, electrolytes, creatine, melatonin, and other supplements, including practical stacking advice and cautions about chronic ketone ester use and possible liver toxicity. Metabolic psychiatry and seizure research (Priority: 4/5): Dom describes evidence that ketogenic therapies may help bipolar disorder, depression, schizophrenia, anxiety, and epilepsy by shifting neurotransmitter balance, reducing inflammation, and altering immune function. Biomarkers, devices, and personalized monitoring (Priority: 4/5): The conversation covers glucose-ketone index, CGMs, insulin, hsCRP, ApoB, OGTT, and ketone meters, with emphasis on using objective data to tailor diet and therapy. Hyperbaric oxygen and adjunctive therapies (Priority: 3/5): Ferriss and Dom discuss HBOT as a potentially useful recovery and therapeutic tool, especially when paired with ketones to reduce oxygen toxicity risk and support neurological or cancer-related applications.
Key Arguments: Ketones are not just an energy source; beta-hydroxybutyrate also acts as a signaling molecule that can affect inflammation, gene expression, and cellular defense. Alzheimer’s involves brain energy failure, glucose hypometabolism, neuroinflammation, and possibly infectious contributors; ketones can partially bypass the energy deficit. Exogenous ketones can help, but they are not identical: salts, esters, and MCTs differ in absorption, effect, and safety profile. Chronic use of some 1,3-butanediol-based ketone esters may pose liver-toxicity concerns, so cycling and moderation matter. A “Goldilocks” ketone range around 1.2–2.0 mmol/L may be anxiolytic, while excessive ketone spikes can feel anxiogenic for some people. Sardine fasting is presented as a practical fast-mimicking strategy that may preserve nutrition better than water fasting, especially for cancer patients. Ketogenic therapies may help psychiatric and seizure disorders by shifting the GABA/glutamate balance, reducing neuroinflammation, and modulating immune function. Objective biomarkers such as hsCRP, insulin, ApoB, OGTT, and CGM data are essential because fasting glucose alone can miss metabolic dysfunction. Ketones may complement hyperbaric oxygen therapy by reducing oxygen toxicity risk and potentially improving recovery or neurological outcomes. Melatonin, despite animal concerns, may be safe and useful in humans for neuroprotection and sleep when used thoughtfully and monitored.
Data Points: Ketone target range: 1.2–2.0 mmol/L - Ferriss and D’Agostino describe this as a “Goldilocks” zone that may reduce anxiety and support ketosis benefits. GKI target range: 1–2 ideal; 1–5 still great - Discussed as a useful metabolic target for therapeutic ketosis and autophagy-related goals. Normal U.S. GKI: ~25–50 - Dom contrasts typical U.S. metabolic status with therapeutic ketosis. Potential chronic ketone ester threshold: >100 mL/day - Mentioned as a level where chronic use of some 1,3-butanediol-based ketone esters may raise concern. Ketone elevation with MCT + BHB: Higher than either alone - Ferriss cites Dom’s explanation that combining exogenous BHB with MCT increases ketone levels more effectively. MCT effect on ketone duration: Slows absorption and sustains elevation - Used to explain why MCT can extend the ketone response from salts/esters. Ketone meter comparison: Keto-Mojo ~10% high; Precision Extra ~20% high - Dom says their lab assays found these devices read higher than their biological assays. Creatine dose for advanced Alzheimer’s: 10–20 g/day - Dom suggests higher creatine dosing may be useful in advanced Alzheimer’s if tolerated. Vitamin D target: ~60–80 ng/mL - Dom recommends checking levels and keeping them in this range rather than exceeding 100. Melatonin dose: 5–10 mg nightly; 20–30 mg tested without suppression - Dom reports long-term use and says human labs did not show endocrine suppression in his case. Body weight: 218–220 lb - Dom gives his current weight during the discussion. Body fat: 9.4% - Reported from a recent DEXA scan. Fiber intake: ~30–40 g/day - Dom says his low-carb diet still includes substantial fiber from broccoli, berries, and other foods. Carb intake: ~50–100 g/day - Dom’s general low-carb Mediterranean-style intake. Wine frequency: Every other night - Dom says he often has one glass of dry wine with activity and an evening walk. Hyperbaric oxygen protocol: 2.4 ATA or higher - Ferriss references medical-grade HBOT facilities at this pressure range. HBOT study scale: $28 million - Dom mentions a large USF hyperbaric oxygen study. Ketogenic adaptation in rodents: ~2 weeks - Dom cites transporter and enzyme upregulation after two weeks in animal models. Sardine fasting cadence: Once per month to every two months - Dom says Fred Hatfield typically did a week-long sardine fast on this schedule.
Pivotal Quotes: "ketones are far more than just fuel" — Tim Ferriss: Ferriss summarizes Dom’s view that ketones have signaling and therapeutic roles beyond energy. "I like to call it, you know, dementia cognitive dementia" — Dr. Dominic D'Agostino: Dom explains why he prefers a broader framing of Alzheimer’s as a metabolic and cognitive disorder. "the beauty of ketogenic therapies is that it's pleiotropic" — Dr. Dominic D'Agostino: Dom argues that ketogenic interventions work through multiple synergistic mechanisms rather than a single pathway.
Implications: Listeners get a practical, data-driven view of ketosis as a therapeutic tool, not a fad. The episode suggests future care may combine diet, ketones, biomarkers, and adjuncts like HBOT for personalized prevention and treatment of neurodegeneration, cancer, and psychiatric disease.
About The Tim Ferriss Show
Tim Ferriss is a self-experimenter and bestselling author, best known for The 4-Hour Workweek. In this show, he deconstructs world-class performers from eclectic areas (investing, sports, business, art, etc.) to extract the tactics, tools, and routines you can use.